Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Breast (Edinburgh, Scotland)|June 29, 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidenceRodrigo Sanchez-Bayona, Carey Anders, Rupert Bartsch, et al.BMJ Open|November 10, 2022
Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and WalesOlivia V Swann, Nazir I Lone, Ewen M Harrison, et al.Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO StudyNicholas C Turner, Judith Balmaña, Coralie Poncet, et al.JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.Journal of the National Cancer Institute|November 9, 2014
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchMartine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, et al.Ebiomedicine|August 20, 2015
Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in CancerFrancisco J Candido Dos Reis, Stuart Lynn, H Raza Ali, et al.Pageof 19